Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10176
PUT
Atlanticus Holdings
ATLC
$1.52B
| $190K | ﹤0.01% |
7,000
+1,800
| +35% | +$54.2K |
|
10177
CALL
Kforce
KFRC
$1.02B
| $190K | ﹤0.01% |
3,000
+1,800
| +150% | +$107K |
|
10178
PUT
Astrana Health
ASTH
$1.97B
| $190K | ﹤0.01% |
5,200
-3,700
| -42% | -$130K |
|
10179
CALL
Dragonfly Energy
DFLI
$18M
| $190K | ﹤0.01% |
+702
| New | +$386K |
|
10180
CALL
Genpact
G
$5.66B
| $190K | ﹤0.01% |
+4,100
| New | +$191K |
|
10181
PUT
Dream Finders Homes
DFH
$1.37B
| $189K | ﹤0.01% |
14,300
+1,400
| +11% | +$16.5K |
|
10182
PUT
TFS Financial
TFSL
$4.91B
| $189K | ﹤0.01% |
15,000
-1,200
| -7% | -$16.8K |
|
10183
NN Inc
NNBR
$339M
| $189K | ﹤0.01% |
177,001
+137,402
| +347% | +$244K |
|
|
PRPH
10184
DELISTED
ProPhase Labs
PRPH
| $189K | ﹤0.01% |
2,485
+1,396
| +128% | +$113K |
|
10185
CALL
ProShares UltraShort Silver
ZSL
$61.9M
| $189K | ﹤0.01% |
255
-88
| -26% | -$77K |
|
|
ADAM
10186
CALL
Adamas Trust
ADAM
$910M
| $189K | ﹤0.01% |
19,000
-2,950
| -13% | -$32K |
|
|
PGAL
10187
DELISTED
Global X MSCI Portugal ETF
PGAL
| $189K | ﹤0.01% |
18,021
+1,672
| +10% | +$17.4K |
|
10188
PUT
Capricor Therapeutics
CAPR
$433M
| $189K | ﹤0.01% |
44,800
-39,800
| -47% | -$171K |
|
10189
Natural Gas Services Group
NGS
$493M
| $189K | ﹤0.01% |
18,337
-16,393
| -47% | -$180K |
|
10190
Atlanta Braves Holdings Series B
BATRK
$3.38B
| $189K | ﹤0.01% |
5,609
-44,867
| -89% | -$1.51M |
|
10191
CALL
Douglas Emmett
DEI
$1.94B
| $189K | ﹤0.01% |
15,300
+12,300
| +410% | +$178K |
|
10192
CALL
Avita Medical
RCEL
$244M
| $189K | ﹤0.01% |
13,500
-38,800
| -74% | -$413K |
|
10193
CALL
Grupo Cibest SA
CIB
$22.8B
| $188K | ﹤0.01% |
7,500
+2,100
| +39% | +$56.7K |
|
|
CBAY
10194
PUT
DELISTED
Cymabay Therapeutics
CBAY
| $188K | ﹤0.01% |
21,600
+4,700
| +28% | +$37.6K |
|
10195
CALL
Shenandoah Telecom
SHEN
$699M
| $188K | ﹤0.01% |
9,900
+1,400
| +16% | +$26.2K |
|
10196
Invesco S&P SmallCap Energy ETF
PSCE
$108M
| $188K | ﹤0.01% |
4,061
-5,762
| -59% | -$289K |
|
10197
Spok Holdings
SPOK
$230M
| $188K | ﹤0.01% |
18,556
-21,789
| -54% | -$199K |
|
10198
PUT
State Street SPDR S&P Kensho New Economies Composite ETF
KOMP
$2.83B
| $188K | ﹤0.01% |
4,400
+3,400
| +340% | +$145K |
|
10199
CALL
Eos Energy Enterprises
EOSE
$1.43B
| $188K | ﹤0.01% |
73,100
+10,200
| +16% | +$17.7K |
|
|
MESO
10200
Mesoblast
MESO
$2.21B
| $188K | ﹤0.01% |
28,533
-40,233
| -59% | -$266K |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.